The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

“You give me butterflies everyday… literally. Happy Birthday PBM,” he captioned his hard launch post. Elaine is a photographer “who enjoys taking environmental portraits,” according to her website.

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

Donald Trump will be the 47th President of the U.S. Not since 1892 has a President been elected to two non-consecutive terms, ...

Analyst Allen Lutz of Bank of America Securities reiterated a Sell rating on GoodRx Holdings (GDRX – Research Report), reducing the price ...

Number 5: By expanding educational initiatives to clarify biosimilar safety, efficacy, and interchangeability, stakeholders can foster trust, improve access, and ensure that biosimilars are widely ...

"This case involves an unlawful price-fixing agreement among several PBMs—orchestrated by the PBM rate aggregator, GoodRx—to ...

There is a tendency to overlook the multiple factors and stakeholders that contributed to the Rx opioid crisis. This includes ...

When a well-established local pharmacy can’t fill a prescription because doing so would cost the pharmacy money, it signals a ...

The Pacific Bus Museum welcomes historic Fageol Bus #216 back to the Bay Area, reuniting the community with a beloved ...

Arkansas Attorney General Tim Griffin said his office was involved in the arrest of three individuals in separate incidents ...